ARTES enters into a partnership with Henkel in a 3‑year research program

ARTES Biotech­nol­o­gy GmbH today announces the col­lab­o­ra­tion with Henkel in a joint three years research pro­gram that is grant­ed by the Ger­man nation­al BMBF (Ger­man Min­is­tery of Edu­ca­tion and Research) with­in the CLIB2021 clus­ter (Wet­tbe­werb Indus­trielle Biotech­nolo­gie 2021). The coop­er­a­tion aims at the devel­op­ment and man­u­fac­tur­ing of pep­tides with adhe­sive properties.

ARTES will apply its pro­pri­etary tech­nol­o­gy plat­forms – the yeast expres­sion tech­nolo­gies Hansenu­la and Arx­u­la and the Chap­er­one tech­nol­o­gy for improved secre­tion. The gen­er­a­tion of pro­duc­tion cell lines, ana­lyt­i­cal assay devel­op­ment, and lab-scale fermentation/down stream process devel­op­ment are ARTES´ respon­si­bil­i­ties in this coop­er­a­tion. Inno­v­a­tive strate­gies for the pro­duc­tion of dif­fi­cult-to-express adhe­sive pep­tides shall be devel­oped, result­ing in next gen­er­a­tion tools for ARTES´ con­tract R&D.

New Scientific Board Member

Prof. Dr. em. Her­mann Sahm

As the for­mer direc­tor of the Insti­tute of Biotech­nol­o­gy at the Research Cen­ter of Jülich, Prof. Dr. em. Her­mann Sahm‘s main fields of inter­est in the last three decades were phys­i­ol­o­gy, enzy­mol­o­gy and mol­e­c­u­lar biol­o­gy of biotech­ni­cal amino acid, vit­a­min and ethanol pro­duc­tion by means of a vari­aty of dif­fer­ent microor­gan­isms. He is an expert in the field of improve­ment and opti­miza­tion of pro­duc­tion strains by meta­bol­ic engi­neer­ing. We are real­ly proud to wel­come Prof. Dr. em. Sahm as our new board mem­ber and we would be pleased that he will sup­port ARTES Biotech­nol­o­gy as con­sul­tant and net­work part­ner. We are look­ing for­ward to a suc­cess­ful relationsship.

New Scientific Board Member

Prof. Dr. Hol­ger Zorn,
Uni­ver­si­ty of tech­nol­o­gy, Dort­mund, leader of the work group tech­no­log­i­cal biochemistry.

Prof. Dr. Zorn is an expert in the field of indus­tri­al bio­engi­neer­ing and white biotech­nol­o­gy and here in detail for extrac­tion of enzymes from basid­iomycete fun­gi. We are real­ly proud to wel­come Prof. Zorn as our new board mem­ber and we would be pleased that he will sup­port ARTES Biotech­nol­o­gy as con­sul­tant and net­work part­ner. We are look­ing for­ward to a suc­cess­ful relationship.